J. Anim Sci.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vallet, J. L.
Right arrow Articles by Christenson, R. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Vallet, J. L.
Right arrow Articles by Christenson, R. K.

Journal of Animal Science, Vol 74, Issue 3 603-609, Copyright © 1996 by American Society of Animal Science

JOURNAL ARTICLE

Effect of prepubertal retinyl palmitate treatment on uterine development and subsequent uterine capacity in swine

J. L. Vallet and R. K. Christenson
USDA, ARS, Roman L. Hruska U. S. Meat Animal Research Center, Clay Center NE 68933, USA.

The effect of prepubertal retinyl palmitate treatment on uterine development and uterine capacity was determined. Gilts remained intact or were unilaterally hysterectomized-ovariectomized (UHO) on d 28, 84, or 112 of age. Starting at birth, half of the gilts in each UHO group were treated with retinyl palmitate (14,000 IU.kg-1.wk-1) and half received control carrier solution. All intact gilts received control carrier solution. Blood samples (d 28, 56, 84, and 112 of age) were analyzed for retinoid and retinol-binding protein (RPB). At UHO, part of the excised uterine horn was processed for morphometric analysis of the uterine wall, and tissues were incubated in minimal essential medium with [3H]leucine to assess total protein and RBP production. After puberty, gilts were mated and then killed on d 44 to 47 of pregnancy; uterine length, number of corpora lutea and fetuses, and fetal, placental, and empty uterine weights were recorded. Endometrial tissues were incubated in minimal essential medium with [3H]leucine, and nondialyzable radioactivity, acid phosphatase, and RBP production were measured. During the prepubertal period, retinyl palmitate treatment decreased (P < .05) myometrial area (longitudinal and circular), but it had no effect on other components of the uterine wall or production of nondialyzable radioactivity or secretion of RBP by uterine tissue. During pregnancy, prepubertal retinyl palmitate treatment increased (P < .05) uterine length but had no effect on uterine weight, number of fetuses, placental or fetal weights, or endometrial production of nondialyzable radioactivity, acid phosphatase, or RBP. Therefore, prepubertal retinyl palmitate treatment at the dosage administered had no effect on uterine capacity.


This article has been cited by other articles:


Home page
 International Journal of ToxicologyHome page
Annual Review of Cosmetic Ingredient Safety Assessments: 2005/2006
International Journal of Toxicology, January 1, 2008; 27(1_suppl): 77 - 142.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society of Animal Science.